Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Leon nanodrugs

Request full access

Leon-nanodrugs is a nanotechnology-based drug development company focused on novel reformulations and reinventions of established drugs

Munich, GermanyFounded 2011Biotech & Life Sciences

About Leon nanodrugs

Leon-nanodrugs GmbH is a Munich-based company specializing in nanotechnology for the pharmaceutical industry. The company revitalizes forgotten formulations, breathes new life into generics, and expedites active pharmaceutical ingredients (APIs) to deliver enhanced bioavailability, increased solubility, and improved stability. Leon-nanodrugs serves pharmaceutical companies looking to improve the efficacy and stability of their drug formulations. Operating in the highly specialized nanotechnology market, the company leverages its proprietary technology to create value for its partners and address unmet medical needs. The business model revolves around providing novel, ready-to-use, validated nano solutions that enhance the performance of pharmaceutical products. Revenue is generated through partnerships, licensing agreements, and service contracts with pharmaceutical companies.

Source: Dealroom company data

At a glance

Status
Operational
Employees
20
Open positions
None listed
Dealroom signal
87.6/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Drug Development, Tech for Biotech and Pharma, Techbio, Woman Founder, DT and LS
Technology
Hardware, Deep Tech, Nanotech
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VC✓Equity / VC Feb 2026 $0 — Undisclosed ↗
SERIES DEquity / VC Aug 2024 $0 — Signet Healthcare Partners · CD-Venture · TVM Capital Life Science —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearProfitMargin
2026 —
2025 —
2024 —
2023 —
2022 —
2021 —
2020 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Leon nanodrugs website traffic

Latest recorded traffic for Leon nanodrugs is 1.3K monthly website visits, up 306.3% over the last three months. Leon nanodrugs's team grew 53.8% over the past year.

Latest monthly visits1.3K 3-month web change+306.3% 1-year team growth+53.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Leon nanodrugs in the Munich ecosystem

Live from Dealroom

The Leon nanodrugs office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A8 investors entered at this stage

  • TVM Capital Life Science
  • Signet Healthcare Partners
  • CD-Venture
  • LifeCare Partners
  • Evotec
  • Albany Private Equity Holdings
  • LOF Leon Partnership
  • Eckenstein-Geigy-Stiftung

Other known investors3 additional known investors

  • Bavarian SME Equity Investment Company
  • BayBG Venture Capital
  • LBBW Venture Capital
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇩🇪 Germany81.3%
🇺🇸 United States12.5%
🇨🇭 Switzerland6.3%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Leon nanodrugs on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Leon nanodrugs’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.